(1)
Evaluating Knowledge And Awareness Of SGLT-2 Inhibitors’ Use, Efficacy, Side Effects, And Cardiovascular And Renal Impacts Among Primary Healthcare Physicians In Makkah, Saudi Arabia. Rev Diabet Stud 2025, 490-500. https://doi.org/10.70082/rr96vh76.